Top Industry Leaders in the Cosmetic Dentistry Market
Latest Cosmetic Dentistry Companies Update
-
Sep 2023: Months after the US health agency approved the drug, Sage Therapeutics said that the oral postpartum depression (PPD) pill it created with partner Biogen is priced at $15,900 for a complete 14-day course of treatment. The Food and Drug Administration only approved Zurzuvae for postpartum depression in August, despite the companies' request for clearance to treat clinical depression, a far larger market. The first oral medication for the illness that affects one in seven moms after giving birth is called Zurzuvae. Zulresso, another injectable PDD therapy manufactured by Sage, is $34,000 annually. The $15,900 wholesale acquisition price for therapy with Zurzuvae was reportedly below the forecasts of at least two analysts.
-
Jan 2023: The fast-expanding clear aligner firm Byte and DENTSPLY SIRONA Inc. announced that Dentsply Sirona has bought Byte for $1.04 billion in total cash. Byte is a market leader in the quickly expanding doctor-directed, direct-to-consumer clear aligner sector. Dentsply Sirona expands the size of its SureSmile® clear aligner business and fortifies its relationship with dental professionals because of the purchase. The revolutionary direct-to-consumer approach that Byte offers and Dentsply Sirona's global reach and supply chain capabilities position the merged company's clear aligner platform for future growth.
List of Cosmetic Dentistry Key companies in the market
- 3M Company
- Danaher Corporation
- BioHorizons
- Dentsply International Inc.
- Institut Straumann AG
- Zimmer Biomet Holding Inc.
- Align Technology Inc.
- Sirona Dental Systems Inc.
- Biolase Inc.
- Planmeca Oy
- A-dec Inc.